A Novel Amphiphilic Chitosan-based Injectable Nanogel with Sustain Release of Insulin for Anti-diabetic medication
碩士 === 國立交通大學 === 材料科學與工程學系所 === 103 === Diabetes is a predominant public health concern, according to International Diabetes Federation (I.D.F), 382 million people are diagnosed with diabetes worldwide in 2013 and this number estimate increase to 592 million in 2035. Since diabetes cannot be cured,...
Main Authors: | Chen,Yi-Chieh, 陳怡潔 |
---|---|
Other Authors: | Liu, Dean-Mo |
Format: | Others |
Language: | en_US |
Published: |
2014
|
Online Access: | http://ndltd.ncl.edu.tw/handle/sgj7m8 |
Similar Items
-
A Novel Amphiphilic Chitosan-based Injectable Nanogel with Sustain Release of Latanoprost for Anti-glaucoma Treatment
by: Wang, Yi-Ling, et al.
Published: (2013) -
Design of polysaccharide-based nanogels for the controlled release of insulin
by: Poirot, Robin
Published: (2017) -
Injectable Insulin-Lysozyme-Loaded Nanogels with Enzymatically-Controlled Degradation and Release for Blood Glucose Control
by: Chou, Hao-Syun, et al.
Published: (2016) -
Development of pH-responsive polymeric nanogels for delivery of amphiphilic drug molecules
by: Shu-Chiao Liao, et al.
Published: (2019) -
Amphiphilic nanogels: influence of surface hydrophobicity on protein corona, biocompatibility and cellular uptake
by: Bewersdorff T, et al.
Published: (2019-09-01)